X4 Pharmaceuticals - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $95,319.86 -0.78%
Ethereum $3,298.36 -0.88%
BNB $661.74 +0.55%
Optimism $1.78 +2.19%
Arbitrum $0.75 +1.35%
Solana $181.79 -1.31%
Polygon $0.47 +0.15%
Cosmos $6.41 -1.36%
Avalanche $36.27 -3.52%

Bitcoin $95,319.86 -0.78%
Ethereum $3,298.36 -0.88%
BNB $661.74 +0.55%
Optimism $1.78 +2.19%
Arbitrum $0.75 +1.35%
Solana $181.79 -1.31%
Polygon $0.47 +0.15%
Cosmos $6.41 -1.36%
Avalanche $36.27 -3.52%

X4 Pharmaceuticals

company

Investors

Number of Lead Investors

Number of Investors

5

17

X4 Pharmaceuticals is funded by 17 investors. Acorn Bioventures and Lumira Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Acorn Bioventures	Yes	Post-IPO Equity
Lumira Ventures	Yes	Post-IPO Equity
New Enterprise Associates	Yes	Post-IPO Equity
Cormorant Asset Management	Yes	Series B
Hercules Capital	-	Post-IPO Equity
AXA Investment Managers	-	Post-IPO Equity
Bain Capital Life Sciences	-	Post-IPO Equity
OrbiMed	-	Post-IPO Equity
Abingworth	-	Post-IPO Equity
Altium Capital	-	Post-IPO Equity
Driehaus Capital Management	-	Post-IPO Equity
Ikarian Capital	-	Post-IPO Equity
Lincoln Park Capital Fund	-	Post-IPO Equity
Monashee Investment Management	-	Post-IPO Equity
Sio Capital Management	-	Post-IPO Equity
Thynk Capital, LLC.	-	Series A
SV Health Investors	-	Seed